NovaBay Pharmaceuticals

Warning letter

Headquarters

United States of America

Issue date

2 Nov 2020

Issuing office

Center for Drug Evaluation and Research | CDER

Posted date

3 Nov 2020

Subject

Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

Products & Services

Drugs